New study to develop personalized therapies for triple-negative breast cancer patients

Indiana University School of Medicine researcher Bryan P. Schneider, MD, is leading a novel nationwide study to better understand how to treat patients with triple-negative breast cancer based on their own unique genetic data.

source https://medicalxpress.com/news/2021-10-personalized-therapies-triple-negative-breast-cancer.html